| Scynexis, Inc. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120010131 | NOVEL CYCLOSPORIN ANALOGUES - The invention relates to the use of cyclic compounds of general formula (I): | 01-12-2012 |
| 20110224228 | ANTIFUNGAL AGENTS - Novel derivatives of enfumafungin are disclosed herein, along with' their pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds, methods of preparing such compounds and method of using such compounds as antifungal agents and/or inhibitors of (1,3)-β-D-glucan synthase. The disclosed compounds, their pharmaceutically acceptable salts, hydrates and prodrugs, as well as compositions comprising such compounds, salts, hydrates and prodrugs, are useful for treating and/or preventing fungal infections and associated diseases and conditions. | 09-15-2011 |
| 20110172225 | ANTIFUNGAL AGENTS - Novel derivatives of enfumafungin are disclosed herein, along with their, pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds, methods of preparing such compounds and methods of using such compounds as antifungal agents and/or inhibitors of (1,3)-β-D-glucan synthase. The disclosed compounds, their pharmaceutically acceptable salts, hydrates and prodrugs, as well as compositions comprising such compounds, salts, hydrates and prodrugs, are useful for treating and/or preventing fungal infections and associated diseases and conditions. | 07-14-2011 |
| 20100227801 | PHARMACEUTICAL COMPOSITIONS - This invention relates to combinations comprising 3-[(R)-2-(N,N-dimethylamino)ethylthio-Sar]-4-(gammahydroxymethylleucine)cyclosporine, or a pharmaceutically acceptable salt, solvate or hydrate thereof; and certain nucleoside analogues, and their use in the treatment of hepatitis C virus. | 09-09-2010 |
| 20100173837 | DOSING FORMS AND REGIMENS COMPRISING 3-[(R)-2-(N,N-DIMETHYLAMINO)ETHYLTHIO-SAR]-4-(GAMMAHYDROXYMETHYLLEUCINE)C- YCLOSPORINE - Provided herein are specific doses of, and dosing regimens for, using SCY-635 in treating or preventing diseases, in particular hepatitis C virus (HCV) infection. | 07-08-2010 |
| 20100113439 | Antifungal agents - Novel derivatives of enfumafungin are disclosed herein, along with their pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds, methods of preparing such compounds and methods of using such compounds as antifungal agents and/or inhibitors of (1,3)-β-D-glucan synthase. The disclosed compounds, their pharmaceutically acceptable salts, hydrates and prodrugs, as well as compositions comprising such compounds, salts, hydrates and prodrugs, are useful for treating and/or preventing fungal infections and associated diseases and conditions. | 05-06-2010 |
| 20090298751 | Arylalkyl and Heteroarylalkyl Derivaties of Cyclosporine a for the Treatment and Prevention of Viral Infection - This invention provides compounds of general formula (T): (I) wherein A, B, R | 12-03-2009 |
